市場調査レポート

商品コード

細胞治療および遺伝子治療の市場規模・予測、世界と地域のシェア、動向、成長機会分析レポート：タイプ別、サービス別、規模別、サービスプロバイダー別、エンドユーザー別、地域別

Cell and Gene Therapy Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Services, Scale, Service Providers, End User, and Geography

出版日: 2024年08月27日
発行: The Insight Partners
ページ情報: 英文 232 Pages
納期: 即納可能

価格

PDF (Single User License)

USD 4,450 648,053円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,450 939,313円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,450 1,230,573円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.63円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

細胞治療および遺伝子治療市場は、2023年の44億8,500万米ドルから2031年には280億5,039万米ドルに成長すると予測されており、2023年から2031年までのCAGRは25.8%を記録すると予測されています。

細胞治療および遺伝子治療市場の分析に寄与した主要セグメントは、サービス、規模、サービスプロバイダー、エンドユーザーです。

細胞治療および遺伝子治療市場は、タイプ別に細胞治療と遺伝子治療に二分されます。2023年の市場シェアは、細胞療法分野が大きいです。細胞療法は、特定の細胞群を修復・変化させたり、体内で治療を行うための細胞を提供したりすることで、障害や疾患の治療に役立ちます。細胞療法は、患者に導入する前に体外で細胞を形成または改変します。細胞は患者由来（自己細胞）またはドナー由来（同種細胞）です。細胞療法分野の成長は、市場に参入する製品数の増加、自己免疫疾患、がん、感染症の治療における細胞療法の潜在的応用、進行中の臨床試験の多さなどに起因しています。

細胞治療および遺伝子治療市場は、サービス別にプロセス開発、cGMP製造、レギュラトリーサービス、バイオアッセイサービスに区分されます。2023年の市場シェアは、プロセス開発分野が大きいです。細胞治療および遺伝子治療市場は、特に製造と送達サービスにおける技術の進歩によって急速な成長を遂げています。このような進歩に伴い、細胞治療および遺伝子治療開発企業は、堅牢でスケーラブルな製造プロセスの開発、高品質な製品の一貫性の確保、特定の治療標的に対する送達方法の最適化に関する専門知識を提供しています。

タイプ別では、市場は通気型と非通気型に区分されます。2023年の市場シェアは、通気型がより大きいです。

細胞治療および遺伝子治療市場は規模別に、商業化前/R&D製造、商業化規模製造に二分されます。2023年には商業化前/R&D製造分野が大きなシェアを占めています。

細胞治療および遺伝子治療市場は、サービスプロバイダー別にCDMOとCMOに分けられます。2023年の市場シェアは、CDMOsセグメントが大きいです。

細胞治療および遺伝子治療市場をエンドユーザー別に見ると、市場は受託研究機関、製薬・バイオ製薬企業、学術・研究機関に区分されます。2023年には製薬・バイオ製薬企業セグメントが市場を独占しました。

細胞治療および遺伝子治療市場調査レポートの調査範囲は、北米（米国、カナダ、メキシコ）、欧州（スペイン、英国、ドイツ、フランス、イタリア、その他欧州地域）、アジア太平洋（韓国、中国、日本、インド、オーストラリア、その他アジア太平洋地域）、中東・アフリカ（南アフリカ、サウジアラビア、アラブ首長国連邦、その他中東・アフリカ地域）、中南米（ブラジル、アルゼンチン、その他中南米地域）です。売上高では、北米が2023年に最大の市場シェアを占めました。一方、アジア太平洋地域は、2023年に最も急成長した世界の細胞治療および遺伝子治療市場を占めました。中国は遺伝子・細胞治療の分野で進歩を遂げています。同国は患者数が多く、これらの治療を開発する企業にとって魅力的な市場となっています。中国では複数の企業ががんや遺伝性疾患などの疾患に対する革新的な治療に取り組んでおり、遺伝子治療の研究開発にも多額の投資を行っています。中国は2003年に遺伝子治療を承認した最初の国です。それ以来、細胞治療と遺伝子治療の開発は世界中で急速に進展し、その治療可能性は急上昇しています。中華人民共和国政府は、細胞治療および遺伝子治療の規範的発展を促進するため、いくつかの規制改革を行ってきました。さらに、各分野で事業を展開するさまざまな市場リーダーの存在が市場拡大に寄与しており、細胞治療および遺伝子治療市場規模の拡大に大きく貢献しています。

欧州連合（EU）、経済協力開発機構（OECD）、国立医学図書館（NLM）は、細胞治療および遺伝子治療市場に関するレポート作成時に参照した一次情報および二次情報の一部です。

細胞治療および遺伝子治療市場- 主な市場力学
市場促進要因
- 細胞治療および遺伝子治療の承認件数の増加
- 細胞治療および遺伝子治療製造のアウトソーシングの急速な普及
市場抑制要因
- 細胞治療および遺伝子治療製造の高コスト
市場機会
- 企業による戦略的取り組み
今後の動向
- 細胞治療および遺伝子治療製造サービスの自動化
促進要因と抑制要因の影響

第6章細胞治療および遺伝子治療市場：世界市場分析

細胞治療および遺伝子治療市場の収益、2021-2031年
細胞治療および遺伝子治療市場の予測分析

第7章細胞治療および遺伝子治療市場分析：タイプ別

細胞治療
遺伝子治療

第8章細胞治療および遺伝子治療市場分析：サービス別

プロセス開発
cGMP製造
レギュラトリーサービス
バイオアッセイサービス

第9章細胞治療および遺伝子治療市場分析：規模別

プレコマーシャル/R&D製造
商業スケール製造

第10章細胞治療および遺伝子治療市場分析：サービスプロバイダー別

CDMO
CMO

第11章細胞治療および遺伝子治療市場分析：エンドユーザー別

受託研究機関
製薬・バイオ医薬品企業
学術・研究機関

第12章細胞治療および遺伝子治療市場：地域別分析

北米
- 米国
- カナダ
- メキシコ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- その他欧州
アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- APACのその他諸国
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- その他中東とアフリカ
中南米
- ブラジル
- アルゼンチン
- その他中南米

第13章業界情勢

細胞治療および遺伝子治療市場における成長戦略
有機的成長戦略
無機的成長戦略

第14章企業プロファイル

Thermo Fisher Scientific Inc.
Merck KGaA
Charles River Laboratories International Inc
Cell and Gene Therapy Catapult
Lonza Group AG
WuXi AppTec Co Ltd
Takara Bio Inc
FUJIFILM Holdings Corp
F. Hoffmann-La Roche Ltd
Catalent Inc
Lotte Corp

第15章付録

図表

List Of Tables

Table 1. Cell and Gene Therapy Market Segmentation
Table 2. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 4. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Cell Therapy
Table 5. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Gene Therapy
Table 6. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Services
Table 7. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Scale
Table 8. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Service Providers
Table 9. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 10. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 11. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 12. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 13. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 14. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 15. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 16. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 17. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 18. United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 19. United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 20. United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 21. United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 22. United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 23. United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 24. United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 25. Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 26. Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 27. Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 28. Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 29. Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 30. Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 31. Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 32. Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 33. Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 34. Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 35. Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 36. Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 37. Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 38. Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 39. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 40. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 41. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 42. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 43. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 44. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 45. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 46. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 47. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 48. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 49. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 50. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 51. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 52. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 53. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 54. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 55. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 56. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 57. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 58. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 59. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 60. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 61. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 62. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 63. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 64. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 65. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 66. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 67. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 68. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 69. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 70. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 71. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 72. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 73. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 74. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 75. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 76. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 77. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 78. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 79. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 80. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 81. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 82. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 83. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 84. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 85. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 86. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 87. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 88. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 89. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 90. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 91. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 92. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 93. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 94. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 95. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 96. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 97. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 98. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 99. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 100. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 101. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 102. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 103. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 104. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 105. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 106. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 107. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 108. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 109. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 110. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 111. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 112. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 113. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 114. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 115. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 116. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 117. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 118. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 119. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 120. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 121. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 122. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 123. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 124. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 125. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 126. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 127. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 128. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 129. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 130. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 131. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 132. Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 133. Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 134. Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 135. Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 136. Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 137. Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 138. Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 139. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 140. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 141. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 142. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 143. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 144. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 145. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 146. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 147. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 148. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 149. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 150. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 151. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 152. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 153. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 154. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 155. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 156. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 157. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 158. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 159. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 160. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 161. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 162. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 163. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 164. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 165. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 166. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 167. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 168. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 169. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 170. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 171. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 172. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 173. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 174. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 175. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 176. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 177. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 178. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 179. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 180. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 181. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 182. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 183. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 184. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 185. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 186. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 187. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 188. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 189. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 190. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 191. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 192. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 193. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 194. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 195. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 196. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 197. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 198. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 199. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 200. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 201. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 202. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 203. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 204. Recent Organic Growth Strategies in Cell and Gene Therapy Market
Table 205. Recent Inorganic Growth Strategies in the Tympanostomy products Market

List Of Figures

Figure 1. Cell and Gene Therapy Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
Figure 5. Cell and Gene Therapy Market Share (%) - by Type (2023 and 2031)
Figure 6. Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Cell and Gene Therapy Market Share (%) - by Services (2023 and 2031)
Figure 9. Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Cell and Gene Therapy Market Share (%) - by Scale (2023 and 2031)
Figure 14. Pre Commercial/R and D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Cell and Gene Therapy Market Share (%) - by Service Providers (2023 and 2031)
Figure 17. CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Cell and Gene Therapy Market Share (%) - by End User (2023 and 2031)
Figure 20. Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Cell and Gene Therapy Market Breakdown by Region, 2023 and 2031 (%)
Figure 24. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 25. North America: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
Figure 26. North America: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
Figure 27. North America: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
Figure 28. North America: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
Figure 29. North America: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 30. United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 31. Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 32. Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 33. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 34. Europe: Cell and Gene Therapy Market Breakdown, by Type (2023 and 2031)
Figure 35. Europe: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
Figure 36. Europe: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
Figure 37. Europe: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
Figure 38. Europe: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
Figure 39. Europe: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 40. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 41. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 42. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 43. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 44. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 45. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 46. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 47. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Type (2023 and 2031)
Figure 48. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
Figure 49. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
Figure 50. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
Figure 51. Asia Pacific: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
Figure 52. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 53. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 54. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 55. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 56. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 57. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 58. Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 59. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 60. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type (2023 and 2031)
Figure 61. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
Figure 62. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
Figure 63. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
Figure 64. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
Figure 65. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 66. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 67. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 68. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 69. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 70. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 71. South and Central America: Cell and Gene Therapy Market Breakdown, by Type (2023 and 2031)
Figure 72. South and Central America: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
Figure 73. South and Central America: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
Figure 74. South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
Figure 75. South and Central America: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
Figure 76. South and Central America: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 77. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 78. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 79. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 80. Growth Strategies in Cell and Gene Therapy Market

Product Code: TIPRE00020854

The cell and gene therapy market is expected to grow from US$ 4,485.00 million in 2023 to US$ 28,050.39 million by 2031; it is anticipated to record a CAGR of 25.8% from 2023 to 2031.

Key segments that contributed to the derivation of the cell and gene therapy market analysis are services, scale, service providers, and end user.

The cell and gene therapy market, by type, the cell and gene therapy market is segmented into bifurcated into cell therapy, gene therapy. The cell therapy segment held a larger market share in 2023. Cell therapy helps treat disorders and diseases by restoring or changing certain groups of cells or providing cells to carry therapy through the body. Cell therapy forms or modifies cells outside the body before introducing into the patient. The cells might derive from the patient (autologous cells) or a donor (allogeneic cells). The growth of the cell therapy segment is attributed to the increasing number of products entering the market, the potential application of cell therapies in treating autoimmune diseases, cancer, and infectious diseases, and the high number of ongoing clinical trials.

The cell and gene therapy market, by services, the market is segmented into process development, cGMP manufacturing, regulatory services, bioassay services. The process development segment held a larger share of the market in 2023. The cell and gene therapy market is witnessing rapid growth driven by technological advancements, particularly in manufacturing and delivery services. With such advancements, cell and gene therapy developers offer expertise in developing robust and scalable manufacturing processes, ensuring high-quality product consistency, and optimizing delivery methods for specific therapeutic targets.

By type, the market is segmented into vented and non-vented. The vented segment held a larger share of the market in 2023.

The cell and gene therapy market, by scale, the market is bifurcated into pre commercial/R and D manufacturing, commercial scale manufacturing. The pre commercial/R and D manufacturing segment held a larger share of the market in 2023.

The cell and gene therapy market, by service provider, the market is divided into CDMOs, CMOs. The CDMOs segment held a larger share of the market in 2023.

The cell and gene therapy market, by end user, the market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, academic and research institutes. The pharmaceutical and biopharmaceutical companies segment dominated the market in 2023.

The scope of the cell and gene therapy market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, Japan, India, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). In terms of revenue, North America accounted for the largest market share in 2023. On the other hand, Asia Pacific region accounted for the fastest-growing global cell and gene therapy market in 2023. China is making progress in gene and cell therapy. The country has a large patient population making it an attractive market for companies developing these treatments. Several companies are working on innovative therapies for diseases such as cancer and genetic disorders in China, and the country has invested heavily in gene therapy research and development. China was the first country to approve gene therapy in 2003; since then, cell and gene therapy developments have advanced rapidly worldwide, and their therapeutic potential has soared. The government of the People's Republic of China has conducted several regulatory reforms to promote the normative development of cell and gene therapies. In addition, the presence of various market leaders operating in the segments is contributing to the market expansion, which contribute notably to the expansion of cell and gene therapy market size.

European Union (EU), Organisation for Economic Co-operation and Development (OECD), and National Library of Medicine (NLM) are a few key primary and secondary sources referred to while preparing the report on the cell and gene therapy market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Cell and Gene Therapy Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Cell and Gene Therapy Market - Key Market Dynamics

5.1 Cell and Gene Therapy Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increase in Number of Approval of Cell and Gene Therapies
- 5.2.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.3 Market Restraints
- 5.3.1 High Cost of Cell and Gene Therapy Manufacturing
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Companies
5.5 Future Trends
- 5.5.1 Automation of Cell and Gene Therapy Manufacturing Services
5.6 Impact of Drivers and Restraints:

6. Cell and Gene Therapy Market - Global Market Analysis

6.1 Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
6.2 Cell and Gene Therapy Market Forecast Analysis

7. Cell and Gene Therapy Market Analysis - by Type

7.1 Cell Therapy
- 7.1.1 Overview
- 7.1.2 Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Gene Therapy
- 7.2.1 Overview
- 7.2.2 Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

8. Cell and Gene Therapy Market Analysis - by Services

8.1 Process Development
- 8.1.1 Overview
- 8.1.2 Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.2 cGMP Manufacturing
- 8.2.1 Overview
- 8.2.2 cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Regulatory Services
- 8.3.1 Overview
- 8.3.2 Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Bioassay Services
- 8.4.1 Overview
- 8.4.2 Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

9. Cell and Gene Therapy Market Analysis - by Scale

9.1 Pre Commercial/R and D Manufacturing
- 9.1.1 Overview
- 9.1.2 Pre Commercial/R and D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Commercial Scale Manufacturing
- 9.2.1 Overview
- 9.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

10. Cell and Gene Therapy Market Analysis - by Service Providers

10.1 CDMOs
- 10.1.1 Overview
- 10.1.2 CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
10.2 CMOs
- 10.2.1 Overview
- 10.2.2 CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

11. Cell and Gene Therapy Market Analysis - by End User

11.1 Contract Research Organizations
- 11.1.1 Overview
- 11.1.2 Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Pharmaceutical and Biopharmaceutical Companies
- 11.2.1 Overview
- 11.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Academic and Research Institutes
- 11.3.1 Overview
- 11.3.2 Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

12. Cell and Gene Therapy Market - Geographical Analysis

12.1 Overview
12.2 North America
- 12.2.1 North America Cell and Gene Therapy Market Overview
- 12.2.2 North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.2.3 North America: Cell and Gene Therapy Market Breakdown, by Type
  - 12.2.3.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
    - 12.2.3.1.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
    - 12.2.3.1.2 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
- 12.2.4 North America: Cell and Gene Therapy Market Breakdown, by Services
  - 12.2.4.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
- 12.2.5 North America: Cell and Gene Therapy Market Breakdown, by Scale
  - 12.2.5.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
- 12.2.6 North America: Cell and Gene Therapy Market Breakdown, by Service Providers
  - 12.2.6.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
- 12.2.7 North America: Cell and Gene Therapy Market Breakdown, by End User
  - 12.2.7.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
- 12.2.8 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.2.8.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.2.8.2 United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.8.2.1 United States: Cell and Gene Therapy Market Breakdown, by Type
    - 12.2.8.2.1.1 United States: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.2.8.2.1.2 United States: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.2.8.2.2 United States: Cell and Gene Therapy Market Breakdown, by Services
    - 12.2.8.2.3 United States: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.2.8.2.4 United States: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.2.8.2.5 United States: Cell and Gene Therapy Market Breakdown, by End User
  - 12.2.8.3 Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.8.3.1 Canada: Cell and Gene Therapy Market Breakdown, by Type
    - 12.2.8.3.1.1 Canada: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.2.8.3.1.2 Canada: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.2.8.3.2 Canada: Cell and Gene Therapy Market Breakdown, by Services
    - 12.2.8.3.3 Canada: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.2.8.3.4 Canada: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.2.8.3.5 Canada: Cell and Gene Therapy Market Breakdown, by End User
  - 12.2.8.4 Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.8.4.1 Mexico: Cell and Gene Therapy Market Breakdown, by Type
    - 12.2.8.4.1.1 Mexico: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.2.8.4.1.2 Mexico: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.2.8.4.2 Mexico: Cell and Gene Therapy Market Breakdown, by Services
    - 12.2.8.4.3 Mexico: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.2.8.4.4 Mexico: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.2.8.4.5 Mexico: Cell and Gene Therapy Market Breakdown, by End User
12.3 Europe
- 12.3.1 Europe Cell and Gene Therapy Market Overview
- 12.3.2 Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.3 Europe: Cell and Gene Therapy Market Breakdown, by Type
  - 12.3.3.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
    - 12.3.3.1.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
    - 12.3.3.1.2 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
- 12.3.4 Europe: Cell and Gene Therapy Market Breakdown, by Services
  - 12.3.4.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
- 12.3.5 Europe: Cell and Gene Therapy Market Breakdown, by Scale
  - 12.3.5.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
- 12.3.6 Europe: Cell and Gene Therapy Market Breakdown, by Service Providers
  - 12.3.6.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
- 12.3.7 Europe: Cell and Gene Therapy Market Breakdown, by End User
  - 12.3.7.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
- 12.3.8 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.3.8.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.3.8.2 United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.8.2.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Type
    - 12.3.8.2.1.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.3.8.2.1.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.3.8.2.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Services
    - 12.3.8.2.3 United Kingdom: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.3.8.2.4 United Kingdom: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.3.8.2.5 United Kingdom: Cell and Gene Therapy Market Breakdown, by End User
  - 12.3.8.3 Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.8.3.1 Germany: Cell and Gene Therapy Market Breakdown, by Type
    - 12.3.8.3.1.1 Germany: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.3.8.3.1.2 Germany: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.3.8.3.2 Germany: Cell and Gene Therapy Market Breakdown, by Services
    - 12.3.8.3.3 Germany: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.3.8.3.4 Germany: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.3.8.3.5 Germany: Cell and Gene Therapy Market Breakdown, by End User
  - 12.3.8.4 France: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.8.4.1 France: Cell and Gene Therapy Market Breakdown, by Type
    - 12.3.8.4.1.1 France: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.3.8.4.1.2 France: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.3.8.4.2 France: Cell and Gene Therapy Market Breakdown, by Services
    - 12.3.8.4.3 France: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.3.8.4.4 France: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.3.8.4.5 France: Cell and Gene Therapy Market Breakdown, by End User
  - 12.3.8.5 Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.8.5.1 Italy: Cell and Gene Therapy Market Breakdown, by Type
    - 12.3.8.5.1.1 Italy: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.3.8.5.1.2 Italy: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.3.8.5.2 Italy: Cell and Gene Therapy Market Breakdown, by Services
    - 12.3.8.5.3 Italy: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.3.8.5.4 Italy: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.3.8.5.5 Italy: Cell and Gene Therapy Market Breakdown, by End User
  - 12.3.8.6 Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.8.6.1 Spain: Cell and Gene Therapy Market Breakdown, by Type
    - 12.3.8.6.1.1 Spain: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.3.8.6.1.2 Spain: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.3.8.6.2 Spain: Cell and Gene Therapy Market Breakdown, by Services
    - 12.3.8.6.3 Spain: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.3.8.6.4 Spain: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.3.8.6.5 Spain: Cell and Gene Therapy Market Breakdown, by End User
  - 12.3.8.7 Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.8.7.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Type
    - 12.3.8.7.1.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.3.8.7.1.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.3.8.7.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Services
    - 12.3.8.7.3 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.3.8.7.4 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.3.8.7.5 Rest of Europe: Cell and Gene Therapy Market Breakdown, by End User
12.4 Asia Pacific
- 12.4.1 Asia Pacific Cell and Gene Therapy Market Overview
- 12.4.2 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.3 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Type
  - 12.4.3.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
    - 12.4.3.1.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
    - 12.4.3.1.2 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
- 12.4.4 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Services
  - 12.4.4.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
- 12.4.5 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Scale
  - 12.4.5.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
- 12.4.6 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Service Providers
  - 12.4.6.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
- 12.4.7 Asia Pacific: Cell and Gene Therapy Market Breakdown, by End User
  - 12.4.7.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
- 12.4.8 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.4.8.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.4.8.2 China: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.8.2.1 China: Cell and Gene Therapy Market Breakdown, by Type
    - 12.4.8.2.1.1 China: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.4.8.2.1.2 China: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.4.8.2.2 China: Cell and Gene Therapy Market Breakdown, by Services
    - 12.4.8.2.3 hina: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.4.8.2.4 China: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.4.8.2.5 China: Cell and Gene Therapy Market Breakdown, by End User
  - 12.4.8.3 Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.8.3.1 Japan: Cell and Gene Therapy Market Breakdown, by Type
    - 12.4.8.3.1.1 Japan: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.4.8.3.1.2 Japan: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.4.8.3.2 Japan: Cell and Gene Therapy Market Breakdown, by Services
    - 12.4.8.3.3 Japan: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.4.8.3.4 Japan: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.4.8.3.5 Japan: Cell and Gene Therapy Market Breakdown, by End User
  - 12.4.8.4 India: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.8.4.1 India: Cell and Gene Therapy Market Breakdown, by Type
    - 12.4.8.4.1.1 India: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.4.8.4.1.2 India: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.4.8.4.2 India: Cell and Gene Therapy Market Breakdown, by Services
    - 12.4.8.4.3 India: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.4.8.4.4 India: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.4.8.4.5 India: Cell and Gene Therapy Market Breakdown, by End User
  - 12.4.8.5 Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.8.5.1 Australia: Cell and Gene Therapy Market Breakdown, by Type
    - 12.4.8.5.1.1 Australia: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.4.8.5.1.2 Australia: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.4.8.5.2 Australia: Cell and Gene Therapy Market Breakdown, by Services
    - 12.4.8.5.3 Australia: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.4.8.5.4 Australia: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.4.8.5.5 Australia: Cell and Gene Therapy Market Breakdown, by End User
  - 12.4.8.6 South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.8.6.1 South Korea: Cell and Gene Therapy Market Breakdown, by Type
    - 12.4.8.6.1.1 South Korea: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.4.8.6.1.2 South Korea: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.4.8.6.2 South Korea: Cell and Gene Therapy Market Breakdown, by Services
    - 12.4.8.6.3 South Korea: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.4.8.6.4 South Korea: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.4.8.6.5 South Korea: Cell and Gene Therapy Market Breakdown, by End User
  - 12.4.8.7 Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.8.7.1 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Type
    - 12.4.8.7.1.1 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.4.8.7.1.2 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.4.8.7.2 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Services
    - 12.4.8.7.3 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.4.8.7.4 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.4.8.7.5 Rest of APAC: Cell and Gene Therapy Market Breakdown, by End User
12.5 Middle East and Africa
- 12.5.1 Middle East and Africa Cell and Gene Therapy Market Overview
- 12.5.2 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.5.3 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type
  - 12.5.3.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
    - 12.5.3.1.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
    - 12.5.3.1.2 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
- 12.5.4 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services
  - 12.5.4.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
- 12.5.5 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale
  - 12.5.5.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
- 12.5.6 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
  - 12.5.6.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
- 12.5.7 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User
  - 12.5.7.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
- 12.5.8 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.5.8.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.5.8.2 South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.8.2.1 South Africa: Cell and Gene Therapy Market Breakdown, by Type
    - 12.5.8.2.1.1 South Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.5.8.2.1.2 South Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.5.8.2.2 South Africa: Cell and Gene Therapy Market Breakdown, by Services
    - 12.5.8.2.3 South Africa: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.5.8.2.4 South Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.5.8.2.5 South Africa: Cell and Gene Therapy Market Breakdown, by End User
  - 12.5.8.3 Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.8.3.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Type
    - 12.5.8.3.1.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.5.8.3.1.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.5.8.3.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Services
    - 12.5.8.3.3 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.5.8.3.4 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.5.8.3.5 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by End User
  - 12.5.8.4 United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.8.4.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Type
    - 12.5.8.4.1.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.5.8.4.1.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.5.8.4.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Services
    - 12.5.8.4.3 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.5.8.4.4 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.5.8.4.5 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by End User
  - 12.5.8.5 Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.8.5.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type
    - 12.5.8.5.1.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.5.8.5.1.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.5.8.5.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services
    - 12.5.8.5.3 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.5.8.5.4 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.5.8.5.5 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User
12.6 South and Central America
- 12.6.1 South and Central America Cell and Gene Therapy Market Overview
- 12.6.2 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.6.3 South and Central America: Cell and Gene Therapy Market Breakdown, by Type
  - 12.6.3.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
    - 12.6.3.1.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
    - 12.6.3.1.2 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
- 12.6.4 South and Central America: Cell and Gene Therapy Market Breakdown, by Services
  - 12.6.4.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
- 12.6.5 South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
  - 12.6.5.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
- 12.6.6 South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
  - 12.6.6.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
- 12.6.7 South and Central America: Cell and Gene Therapy Market Breakdown, by End User
  - 12.6.7.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
- 12.6.8 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.6.8.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.6.8.2 Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.6.8.2.1 Brazil: Cell and Gene Therapy Market Breakdown, by Type
    - 12.6.8.2.1.1 Brazil: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.6.8.2.1.2 Brazil: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.6.8.2.2 Brazil: Cell and Gene Therapy Market Breakdown, by Services
    - 12.6.8.2.3 Brazil: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.6.8.2.4 Brazil: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.6.8.2.5 Brazil: Cell and Gene Therapy Market Breakdown, by End User
  - 12.6.8.3 Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.6.8.3.1 Argentina: Cell and Gene Therapy Market Breakdown, by Type
    - 12.6.8.3.1.1 Argentina: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.6.8.3.1.2 Argentina: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.6.8.3.2 Argentina: Cell and Gene Therapy Market Breakdown, by Services
    - 12.6.8.3.3 Argentina: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.6.8.3.4 Argentina: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.6.8.3.5 Argentina: Cell and Gene Therapy Market Breakdown, by End User
  - 12.6.8.4 Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.6.8.4.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Type
    - 12.6.8.4.1.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.6.8.4.1.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.6.8.4.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Services
    - 12.6.8.4.3 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.6.8.4.4 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.6.8.4.5 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by End User

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in Cell and Gene Therapy Market
13.3 Organic Growth Strategies
- 13.3.1 Overview
13.4 Inorganic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Thermo Fisher Scientific Inc.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Merck KGaA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Charles River Laboratories International Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Cell and Gene Therapy Catapult
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Lonza Group AG
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 WuXi AppTec Co Ltd
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Takara Bio Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 FUJIFILM Holdings Corp
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 F. Hoffmann-La Roche Ltd
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Catalent Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Lotte Corp
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms

細胞治療および遺伝子治療の市場規模・予測、世界と地域のシェア、動向、成長機会分析レポート：タイプ別、サービス別、規模別、サービスプロバイダー別、エンドユーザー別、地域別

Cell and Gene Therapy Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Services, Scale, Service Providers, End User, and Geography

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章細胞治療および遺伝子治療の市場情勢

第5章細胞治療および遺伝子治療市場：主要市場力学

第6章細胞治療および遺伝子治療市場：世界市場分析

第7章細胞治療および遺伝子治療市場分析：タイプ別

第8章細胞治療および遺伝子治療市場分析：サービス別

第9章細胞治療および遺伝子治療市場分析：規模別

第10章細胞治療および遺伝子治療市場分析：サービスプロバイダー別

第11章細胞治療および遺伝子治療市場分析：エンドユーザー別

第12章細胞治療および遺伝子治療市場：地域別分析

第13章業界情勢

第14章企業プロファイル

第15章付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Cell and Gene Therapy Market Landscape

5. Cell and Gene Therapy Market - Key Market Dynamics

6. Cell and Gene Therapy Market - Global Market Analysis

7. Cell and Gene Therapy Market Analysis - by Type

8. Cell and Gene Therapy Market Analysis - by Services

9. Cell and Gene Therapy Market Analysis - by Scale

10. Cell and Gene Therapy Market Analysis - by Service Providers

11. Cell and Gene Therapy Market Analysis - by End User

12. Cell and Gene Therapy Market - Geographical Analysis

13. Industry Landscape

14. Company Profiles

15. Appendix

細胞治療および遺伝子治療の市場規模・予測、世界と地域のシェア、動向、成長機会分析レポート：タイプ別、サービス別、規模別、サービスプロバイダー別、エンドユーザー別、地域別

Cell and Gene Therapy Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Services, Scale, Service Providers, End User, and Geography

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 細胞治療および遺伝子治療の市場情勢

第5章 細胞治療および遺伝子治療市場：主要市場力学

第6章 細胞治療および遺伝子治療市場：世界市場分析

第7章 細胞治療および遺伝子治療市場分析：タイプ別

第8章 細胞治療および遺伝子治療市場分析：サービス別

第9章 細胞治療および遺伝子治療市場分析：規模別

第10章 細胞治療および遺伝子治療市場分析：サービスプロバイダー別

第11章 細胞治療および遺伝子治療市場分析：エンドユーザー別

第12章 細胞治療および遺伝子治療市場：地域別分析

第13章 業界情勢

第14章 企業プロファイル

第15章 付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Cell and Gene Therapy Market Landscape

5. Cell and Gene Therapy Market - Key Market Dynamics

6. Cell and Gene Therapy Market - Global Market Analysis

7. Cell and Gene Therapy Market Analysis - by Type

8. Cell and Gene Therapy Market Analysis - by Services

9. Cell and Gene Therapy Market Analysis - by Scale

10. Cell and Gene Therapy Market Analysis - by Service Providers

11. Cell and Gene Therapy Market Analysis - by End User

12. Cell and Gene Therapy Market - Geographical Analysis

13. Industry Landscape

14. Company Profiles

15. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章細胞治療および遺伝子治療の市場情勢

第5章細胞治療および遺伝子治療市場：主要市場力学

第6章細胞治療および遺伝子治療市場：世界市場分析

第7章細胞治療および遺伝子治療市場分析：タイプ別

第8章細胞治療および遺伝子治療市場分析：サービス別

第9章細胞治療および遺伝子治療市場分析：規模別

第10章細胞治療および遺伝子治療市場分析：サービスプロバイダー別

第11章細胞治療および遺伝子治療市場分析：エンドユーザー別

第12章細胞治療および遺伝子治療市場：地域別分析

第13章業界情勢

第14章企業プロファイル

第15章付録